Validation of an Adapted NGS‐Based Clonality Assay for MRD Monitoring in B‐ALL Using Archived and Follow‐Up Samples

Moushumi Suryavanshi, Prashant Mehta, Nitin Jain, Dinesh Bhurani, Rakesh Reddy Boya, Pravas Chandra Mishra, Dushyant Kumar, Surender Dhandha, Manoj Kumar, Nupur Das, Sweta Mishra · 2025

Read Validation of an Adapted NGS‐Based Clonality Assay for MRD Monitoring in B‐ALL Using Archived and Follow‐Up Samples by Moushumi Suryavanshi, Prashant Mehta, Nitin Jain, Dinesh Bhurani, Rakesh Reddy Boya, Pravas Chandra Mishra, Dushyant Kumar, Surender Dhandha, Manoj Kumar, Nupur Das, Sweta Mishra (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12712541.txt.

Description

Moushumi Suryavanshi led a large team validating a DNA test for leftover leukemia in a 2025 paper. Tracking tiny residual disease guides treatment in a childhood blood cancer, but the standard cell-sorting method misses very low levels. Their adapted sequencing assay was tested on archived slides, preserved tissue, and fresh marrow samples from dozens of patients. Dilution runs set its detection floor, and repeat runs checked stability.

The assay found starting fingerprints in most patients and detected disease down to one cell in a million. It agreed with the standard method in most cases and caught leftover disease weeks earlier in several. Results supported broader clinical use.

Catalog record

CREATORMoushumi Suryavanshi, Prashant Mehta, Nitin Jain, Dinesh Bhurani, Rakesh Reddy Boya, Pravas Chandra Mishra, Dushyant Kumar, Surender Dhandha, Manoj Kumar, Nupur Das, Sweta Mishra
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE26 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12712541

Browse the full library · About the Tower of Babel